New Brunswick, NJ and Santa Clara, CA, April 5, 2024 (JNJ) -- Johnson & Johnson has entered into an agreement to purchase Shockwave Medical Inc. for approximately $13.1 billion, aiming to enhance its presence in cardiovascular and ramp up sales growth and margin. According to a statement released by both companies on Friday, J&J will offer $335 per share in cash for Shockwave, which is headquartered in Santa Clara, California..
Read full article here.
NY, NY, April 18, 2024 (Business Wire) -- Metsera, Inc., a pioneering player in the clinical-stage biopharmaceutical realm focusing on innovative treatments for obesity and metabolic ailments, has e
Cambridge, MA, April 23 2024 (PRNewswire) -- Flare Therapeutics Inc. has undergone a notable leadership transition with the selection of Dr. Douglas Manion, M.D., FRCP (C), as its newly appointed Ch
Wilmington, DE, April 23, 2024 (RTTNews) -- Incyte Corp. (INCY) is buying Escient Pharmaceuticals and its assets for $750 million, plus any cash left over when the deal closes. This acquisition need
